Dermata Therapeutics Inc. (NASDAQ: DRMA) is a biotechnology company, which, as its name suggests, operates in the realm of dermatology. It aims to make a
Dermata Therapeutics, Inc. (DRMA) gained in the pre-market after submitting two-sec filings. DRMA values at $1.40, gaining more than 30% compared to yesterday’s closing price.
Dermata Therapeutics, Inc. (DRMA) is a biopharmaceutical company engaged in bringing the therapeutic potential for different dermatological conditions. One of the lead candidates of the
On January 24, Dermata Therapeutics Inc. (DRMA) stock advanced by a further 8.67% in the after-hours. Before that, the stock had already added 5.49% during
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.